Acuitas Therapeutics Inc. et al v. Alnylam Pharmaceuticals, Inc.

1:24-cv-00816

September 20, 2024
Alnylam Seeks To End Inventorship Suit Tied To COVID Vax

Alnylam Pharmaceuticals, which alleges that COVID-19 vaccines made by Pfizer and Moderna infringe its patents, has moved in Delaware federal court to dismiss a suit by former collaborator Acuitas Therapeutics Inc. seeking to have its scientists added as inventors on the patents.
August 20, 2024
Vax Patent Battles Heat Up As Attention On Pandemic Wanes

It's been over four years since clinical trials began for COVID-19 vaccines, and while the shots have helped the pandemic recede, the lucrative technology has spurred numerous patent suits, many of which are still in the early stages. Here's a look at some of the key cases in the U.S.
July 15, 2024
Acuitas Seeks Credit For IP Tied To COVID Vax

Acuitas Therapeutics wants to set the record straight about its involvement in a handful of patents that Alnylam Pharmaceuticals asserts were swiped to create the COVID-19 vaccine developed by Pfizer, BioNTech and Acuitas, saying in a lawsuit in Delaware federal court Monday that Acuitas scientists should be listed as co-inventors.